Mechanism of resistance to chemotherapy in triple negative breast cancer

被引：0
作者：
Loi, S. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30064-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SA 2.4
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [41] Pembrolizumab plus chemotherapy in triple-negative breast cancer
    Masuda, Jun
    Ozaki, Yukinori
    Hara, Fumikata
    Kitano, Shigehisa
    Takano, Toshimi
    [J]. LANCET, 2021, 398 (10294) : 24 - 24
  • [42] Platinum chemotherapy for early triple-negative breast cancer
    Mason, Sofia RE.
    Willson, Melina L.
    Egger, Sam J.
    Beith, Jane
    Dear, Rachel F.
    Goodwin, Annabel
    [J]. BREAST, 2024, 75
  • [43] Estrogen receptor β4 regulates chemotherapy resistance and induces cancer stem cells in triple negative breast cancer
    Bano, Ayesha
    Stevens, Jessica
    Modi, Paulomi S.
    Strom, Anders
    Gustafsson, Jan-Ake
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [44] Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces Cancer Stem Cells in Triple Negative Breast Cancer
    Bano, Ayesha
    Stevens, Jessica H.
    Modi, Paulomi S.
    Gustafsson, Jan-Ake
    Strom, Anders M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [45] Constitutive Activation of Src Kinase as a Mechanism of Acquired Resistance to Dasatinib in Triple Negative Breast Cancer
    Corkery, B.
    Crown, J.
    Roche, S.
    O'Connor, R.
    Tryfanopoulos, D.
    Clynes, M.
    O'Donovan, N.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 787S - 787S
  • [46] Resistance to neoadjuvant chemotherapy in triple negative breast cancer mediated by a reversible drug-tolerant state
    Echeverria, G. V.
    Ge, Z.
    Seth, S.
    Jeter-Jones, S. L.
    Zhang, X.
    Zhou, X.
    Cai, S.
    Tu, Y.
    Mccoy, A.
    Peoples, M.
    Lau, R.
    Shao, J.
    Sun, Y.
    Bristow, C.
    Carugo, A.
    Ma, X.
    Harris, A.
    Wu, Y.
    Moulder, S.
    Symmans, W. F.
    Marszalek, J. R.
    Heffernan, T. P.
    Chang, J. T.
    Piwnica-Worms, H.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [47] Correlative expression of exosomal miRNAs in chemotherapy resistance of triple-negative breast cancer: An observational study
    Yang, Le
    Fan, Jingjing
    Dong, Chao
    Wang, Xiaoli
    Ma, Binlin
    [J]. MEDICINE, 2024, 103 (35) : e38549
  • [48] Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Donati, Benedetta
    Reggiani, Francesca
    Torricelli, Federica
    Santandrea, Giacomo
    Rossi, Teresa
    Bisagni, Alessandra
    Gasparini, Elisa
    Neri, Antonino
    Cortesi, Laura
    Ferrari, Guglielmo
    Bisagni, Giancarlo
    Ragazzi, Moira
    Ciarrocchi, Alessia
    [J]. CANCER IMMUNOLOGY RESEARCH, 2024, 12 (01) : 120 - 134
  • [49] Circulating exosomal microRNA profiling to depict mechanisms of chemotherapy resistance among triple negative breast cancer
    He, Y.
    Jinhai, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [50] Developing novel lysyl oxidase (LOX) inhibitors to overcome chemotherapy resistance in triple negative breast cancer
    Cetin, Metin
    Saatci, Ozge
    Akbulut, Ozge
    Beneker, Chad
    Rezaeian, Abdol-Hossein
    Chernov, Mikhail
    McInnes, Campbell
    Sahin, Ozgur
    [J]. CANCER RESEARCH, 2023, 83 (05)
12345